A randomized, double-blind, placebo-controlled trial of photopheresis in systemic sclerosis
RM Knobler, LE French, Y Kim, E Bisaccia… - Journal of the American …, 2006 - Elsevier
BACKGROUND: Systemic sclerosis is a multisystemic connective tissue disease with
marked involvement of the skin and joints for which few effective evidence based therapies …
marked involvement of the skin and joints for which few effective evidence based therapies …
[PDF][PDF] A randomized, double-blind, placebo-controlled trial of photopheresis in systemic sclerosis
RM Knobler, LE French, Y Kim, E Bisaccia… - 2006 - researchgate.net
Background: Systemic sclerosis is a multisystemic connective tissue disease with marked
involvement of the skin and joints for which few effective evidence based therapies are …
involvement of the skin and joints for which few effective evidence based therapies are …
A randomized, double-blind, placebo-controlled trial of photopheresis in systemic sclerosis.
RM Knobler, LE French, Y Kim, E Bisaccia… - Journal of the …, 2006 - europepmc.org
Background Systemic sclerosis is a multisystemic connective tissue disease with marked
involvement of the skin and joints for which few effective evidence based therapies are …
involvement of the skin and joints for which few effective evidence based therapies are …
A randomized, double-blind, placebo-controlled trial of photopheresis in systemic sclerosis
RM Knobler, LE French, Y Kim, E Bisaccia… - Journal of the American …, 2006 - jaad.org
Background Systemic sclerosis is a multisystemic connective tissue disease with marked
involvement of the skin and joints for which few effective evidence based therapies are …
involvement of the skin and joints for which few effective evidence based therapies are …
A randomized, double-blind, placebo-controlled trial of photopheresis in systemic sclerosis
RM Knobler, LE French, Y Kim, E Bisaccia… - Journal of the American …, 2006 - infona.pl
Systemic sclerosis is a multisystemic connective tissue disease with marked involvement of
the skin and joints for which few effective evidence based therapies are available. To further …
the skin and joints for which few effective evidence based therapies are available. To further …
[PDF][PDF] A randomized, double-blind, placebo-controlled trial of photopheresis in systemic sclerosis
RM Knobler, LE French, Y Kim, E Bisaccia… - J Am Acad …, 2006 - therakoshcp.ca
Background: The therapeutic options in SSc are limited and are symptom-focused due to
challenges in the assessment of therapeutic response with low disease prevalence, and …
challenges in the assessment of therapeutic response with low disease prevalence, and …
[引用][C] A randomized, double-blind, placebo-controlled trial of photopheresis in systemic sclerosis
RM KNOBLER, LE FRENCH… - Journal of the …, 2006 - pascal-francis.inist.fr
A randomized, double-blind, placebo-controlled trial of photopheresis in systemic sclerosis
CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple …
CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple …
A randomized, double-blind, placebo-controlled trial of photopheresis in systemic sclerosis
RM Knobler, LE French, Y Kim, E Bisaccia… - 2006 - pubmed.ncbi.nlm.nih.gov
Background Systemic sclerosis is a multisystemic connective tissue disease with marked
involvement of the skin and joints for which few effective evidence based therapies are …
involvement of the skin and joints for which few effective evidence based therapies are …